Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01068665

Public ClinicalTrials.gov record NCT01068665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 12:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in South Africa, Europe and North America. The aim of this trial is to compare efficacy and safety of NN1250 (insulin degludec (IDeg)) with insulin glargine (IGlar), as add-on to subject's ongoing treatment with metformin and/or dipeptyl peptidase 4 (DPP-4) inhibitors, in patients with type 2 diabetes being treated with oral anti-diabetic drugs (OADs) qualifying for intensified treatment.

Study identification

NCT ID
NCT01068665
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
460 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2010 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Mar 6, 2017

2010

United States locations

U.S. sites
62
U.S. states
28
U.S. cities
60
Facility City State ZIP Site status
Novo Nordisk Investigational Site Huntsville Alabama 35801 —
Novo Nordisk Investigational Site Gilbert Arizona 85295 —
Novo Nordisk Investigational Site Phoenix Arizona 85018 —
Novo Nordisk Investigational Site Tucson Arizona 85741 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Huntington Beach California 92648 —
Novo Nordisk Investigational Site Mission Hills California 91345 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site National City California 91950 —
Novo Nordisk Investigational Site Norco California 92860 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site Valencia California 91355 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Aurora Colorado 80045-7402 —
Novo Nordisk Investigational Site Hollywood Florida 33021 —
Novo Nordisk Investigational Site Jacksonville Florida 32209-6511 —
Novo Nordisk Investigational Site Longwood Florida 32779 —
Novo Nordisk Investigational Site Ocala Florida 34471 —
Novo Nordisk Investigational Site Ponte Vedra Florida 32081 —
Novo Nordisk Investigational Site Vero Beach Florida 32960 —
Novo Nordisk Investigational Site Decatur Georgia 30033 —
Novo Nordisk Investigational Site Lawrenceville Georgia 30046 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Chicago Illinois 60616 —
Novo Nordisk Investigational Site Crystal Lake Illinois 60012 —
Novo Nordisk Investigational Site Evansville Indiana 47714 —
Novo Nordisk Investigational Site Greenfield Indiana 46140 —
Novo Nordisk Investigational Site Des Moines Iowa 50314-2610 —
Novo Nordisk Investigational Site Madisonville Kentucky 42431 —
Novo Nordisk Investigational Site Slidell Louisiana 70461-4231 —
Novo Nordisk Investigational Site Greenbelt Maryland 20770 —
Novo Nordisk Investigational Site Brockton Massachusetts 02301 —
Novo Nordisk Investigational Site Southfield Michigan 48034 —
Novo Nordisk Investigational Site Southfield Michigan 48075 —
Novo Nordisk Investigational Site Troy Michigan 48098 —
Novo Nordisk Investigational Site Minneapolis Minnesota 55416 —
Novo Nordisk Investigational Site Biloxi Mississippi 39531-4535 —
Novo Nordisk Investigational Site St Louis Missouri 63104 —
Novo Nordisk Investigational Site Billings Montana 59102 —
Novo Nordisk Investigational Site Brick New Jersey 08724 —
Novo Nordisk Investigational Site Mine Hill New Jersey 07803 —
Novo Nordisk Investigational Site Brooklyn New York 11203-2711 —
Novo Nordisk Investigational Site New York New York 10025 —
Novo Nordisk Investigational Site Asheboro North Carolina 27203 —
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Greensboro North Carolina 27408 —
Novo Nordisk Investigational Site Franklin Ohio 45005 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site Melrose Park Pennsylvania 19027 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Peak South Carolina 29122 —
Novo Nordisk Investigational Site DeSoto Texas 75115 —
Novo Nordisk Investigational Site El Paso Texas 79912 —
Novo Nordisk Investigational Site Killeen Texas 76543 —
Novo Nordisk Investigational Site Plano Texas 75093 —
Novo Nordisk Investigational Site Sugar Land Texas 77479 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01068665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2017 · Synced Oct 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01068665 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →